hTERT Extends the Life of Human Fibroblasts without Compromising Type I Interferon Signaling

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Smith, Miles C ^a   Goddard, Erica T ^a,b   Perusina Lanfranca, Mirna ^a   Davido, David J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; VIRUS LARGE T ANTIGEN; TERT PROTEIN, HUMAN;

ARTICLE; CELL AGING; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSE; EMBRYO; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IFIT1 GENE; IFIT2 GENE; INNATE IMMUNITY; INTERFERON PRODUCTION; INTRACELLULAR SIGNALING; ISG15 GENE; MX1 GENE; NONHUMAN; TERT GENE; VESICULAR STOMATITIS; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS REPLICATION; APOPTOSIS; CELL LINE; CELL SURVIVAL; CYTOLOGY; LUNG; METABOLISM; PHYSIOLOGY; SENDAI VIRUS; SIGNAL TRANSDUCTION; VESICULOVIRUS; VIROLOGY;

APOPTOSIS; CELL AGING; CELL LINE; CELL SURVIVAL; FIBROBLASTS; HUMANS; INTERFERON TYPE I; LUNG; SENDAI VIRUS; SIGNAL TRANSDUCTION; TELOMERASE; VESICULOVIRUS; VIRUS REPLICATION;

EID: 84874616587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058233     Document Type: Article

References (103)

1. Fridman AL, Tang L, Kulaeva OI, Ye B, Li Q, et al. (2006) Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton. J Gerontol A Biol Sci Med Sci 61: 879-889.
2. Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, et al. (2003) Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 22: 4118-4127 doi:10.1038/sj.onc.1206594.
3. Shou J, Soriano R, Hayward SW, Cunha GR, Williams PM, et al. (2002) Expression Profiling of a Human Cell Line Model of Prostatic Cancer Reveals a Direct Involvement of Interferon Signaling in Prostate Tumor Progression. PNAS 99: 2830-2835 doi:10.1073/pnas.052705299.
4. Untergasser G, Koch HB, Menssen A, Hermeking H, (2002) Characterization of Epithelial Senescence by Serial Analysis of Gene Expression Identification of Genes Potentially Involved in Prostate Cancer. Cancer Res 62: 6255-6262.
5. Hayflick L, (1965) The limited in vitro lifetime of human diploid cell strains. Experimental Cell Research 37: 614-636 doi:10.1016/0014-4827(65)90211-9.
6. Gilson E, Geli V, (2007) How telomeres are replicated. Nat Rev Mol Cell Biol 8: 825-838 doi:10.1038/nrm2259.
7. Blackburn EH, Greider CW, Henderson E, Lee MS, Shampay J, et al. (1989) Recognition and elongation of telomeres by telomerase. Genome 31: 553-560.
8. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, et al. (1995) The RNA Component of Human Telomerase. Science 269: 1236-1241 doi:10.1126/science.7544491.
9. Zhao Y, Hoshiyama H, Shay JW, Wright WE, (2008) Quantitative Telomeric Overhang Determination Using a Double-Strand Specific Nuclease. Nucl Acids Res 36: e14 doi:10.1093/nar/gkm1063.
10. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts., Published online: 31 May 1990; {pipe} doi:101038/345458a0 345: 458-460. doi:10.1038/345458a0.
11. Neumeister P, Albanese C, Balent B, Greally J, Pestell RG, (2002) Senescence and epigenetic dysregulation in cancer. The International Journal of Biochemistry & Cell Biology 34: 1475-1490 doi:10.1016/S1357-2725(02)00079-1.
12. Campisi J, D' Adda di Fagagna F, (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740 doi:10.1038/nrm2233.
13. Campisi J, (2001) Cellular senescence as a tumor-suppressor mechanism. Trends in Cell Biology 11: S27-S31 doi:10.1016/S0962-8924(01)02151-1.
14. Braig M, Schmitt CA, (2006) Oncogene-Induced Senescence: Putting the Brakes on Tumor Development. Cancer Res 66: 2881-2884 doi:10.1158/0008-5472.CAN-05-4006.
15. Smith JR, Pereira-Smith OM, (1996) Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression. Science 273: 63-67 doi:10.1126/science.273.5271.63.
16. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, et al. (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22: 4212-4222 doi:10.1093/emboj/cdg417.
17. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT, (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. The EMBO Journal 8: 3905.
18. Hudson JB, Bedell MA, McCance DJ, Laiminis LA, (1990) Immortalization and Altered Differentiation of Human Keratinocytes in Vitro by the E6 and E7 Open Reading Frames of Human Papillomavirus Type 18. J Virol 64: 519-526.
19. Shay JW, Wright WE, (1989) Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Experimental Cell Research 184: 109-118 doi:10.1016/0014-4827(89)90369-8.
20. Shay JW, Van Der Haegen BA, Ying Y, Wright WE, (1993) The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 209: 45-52 doi:10.1006/excr.1993.1283.
21. Randall RE, Goodbourn S, (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47 doi:10.1099/vir.0.83391-0.
22. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD, (1998) How Cells Respond to Interferons. Annual Review of Biochemistry 67: 227-264 doi:10.1146/annurev.biochem.67.1.227.
23. Katze MG, He Y, Gale M, (2002) Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2: 675-687 doi:10.1038/nri888.
24. Conrady CD, Halford WP, Carr DJJ, (2011) Loss of the Type I Interferon Pathway Increases Vulnerability of Mice to Genital Herpes Simplex Virus 2 Infection. J Virol 85: 1625-1633 doi:10.1128/JVI.01715-10.
25. Van den Broek MF, Müller U, Huang S, Aguet M, Zinkernagel RM, (1995) Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. Journal of virology 69: 4792-4796.
26. Hwang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, et al. (1995) A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proceedings of the National Academy of Sciences 92: 11284.
27. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional Role of Type I and Type II Interferons in Antiviral Defense. Science 264: 1918-1921 doi:10.1126/science.8009221.
28. Bereczky S, Lindegren G, Karlberg H, Åkerström S, Klingström J, et al. (2010) Crimean-Congo Hemorrhagic Fever Virus Infection Is Lethal for Adult Type I Interferon Receptor-Knockout Mice. J Gen Virol 91: 1473-1477 doi:10.1099/vir.0.019034-0.
29. Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, et al. (2009) Local Type I IFN Receptor Signaling Protects Against Virus Spread Within the Central Nervous System. J Immunol 182: 2297-2304 doi:10.4049/jimmunol.0800596.
30. Durbin JE, Hackenmiller R, Simon MC, Levy DE, (1996) Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease. Cell 84: 443-450 doi:10.1016/S0092-8674(00)81289-1.
31. Fields BN, Knipe DM, Howley PM, Griffin DE (2007) Fields Virology. Lippincott Williams & Wilkins. 1650 p.
32. Smith MC, Boutell C, Davido DJ, (2011) HSV-1 ICP0: paving the way for viral replication. Future Virology 6: 421-429 doi:10.2217/fvl.11.24.
33. Paladino P, Mossman KL, (2009) Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res 29: 599-607 doi:10.1089/jir.2009.0074.
34. Paladino P, Collins SE, Mossman KL, (2010) Cellular Localization of the Herpes Simplex Virus ICP0 Protein Dictates Its Ability to Block IRF3-Mediated Innate Immune Responses. PLoS ONE 5: e10428 doi:10.1371/journal.pone.0010428.
35. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, et al. (1997) hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization. Cell 90: 785-795 doi:10.1016/S0092-8674(00)80538-3.
36. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, et al. (1998) Extension of Life-Span by Introduction of Telomerase into Normal Human Cells. Science 279: 349-352 doi:10.1126/science.279.5349.349.
37. Franco S, MacKenzie KL, Dias S, Alvarez S, Rafii S, et al. (2001) Clonal Variation in Phenotype and Life Span of Human Embryonic Fibroblasts (MRC-5) Transduced with the Catalytic Component of Telomerase (hTERT). Experimental Cell Research 268: 14-25 doi:10.1006/excr.2001.5264.
38. O'Sullivan RJ, Karlseder J, (2010) Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 11: 171-181 doi:10.1038/nrm2848.
39. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, et al. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21: 115-118 doi:10.1038/5063.
40. Smith MC, Bayless AM, Goddard ET, Davido DJ, (2011) CK2 inhibitors increase the sensitivity of HSV-1 to interferon-[beta]. Antiviral Research 91: 259-266 doi:16/j.antiviral.2011.06.009.
41. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM, et al. (2001) Herpes Simplex Virus Triggers and Then Disarms a Host Antiviral Response. J Virol 75: 750-758 doi:10.1128/JVI.75.2.750-758.2001.
42. Samaniego LA, Wu N, DeLuca NA, (1997) The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol 71: 4614-4625.
43. Counter CM, Hahn WC, Wei W, Dickinson Caddle S, Beijersbergen RL, et al. (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proceedings of the National Academy of Sciences of the United States of America 95: 14723-14728.
44. Misawa K, Nosaka T, Morita S, Kaneko A, Nakahata T, et al. (2000) A Method to Identify cDNAs Based on Localization of Green Fluorescent Protein Fusion Products. PNAS 97: 3062-3066 doi:10.1073/pnas.97.7.3062.
45. Dimmer EC, Huntley RP, Alam-Faruque Y, Sawford T, O'Donovan C, et al. (2012) The UniProt-GO Annotation database in 2011. Nucleic Acids Res 40: D565-D570 doi:10.1093/nar/gkr1048.
46. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, et al. (2002) Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation. Mol Cell Biol 22: 2111-2123 doi:10.1128/MCB.22.7.2111-2123.2002.
47. Smith KO, (1964) Relationship Between the Envelope and the Infectivity of Herpes Simplex Virus. Proc Soc Exp Biol Med 115: 814-816.
48. Cai WZ, Schaffer PA, (1989) Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol 63: 4579-4589.
49. Schaffer PA, Aron GM, Biswal N, Benyesh-Melnick M, (1973) Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology 52: 57-71.
50. Davido DJ, Zagorski WF, Lane WS, Schaffer PA, (2005) Phosphorylation Site Mutations Affect Herpes Simplex Virus Type 1 ICP0 Function. Journal of Virology 79: 1232-1243 doi:10.1128/JVI.79.2.1232-1243.2005.
51. Das SC, Nayak D, Zhou Y, Pattnaik AK, (2006) Visualization of Intracellular Transport of Vesicular Stomatitis Virus Nucleocapsids in Living Cells. J Virol 80: 6368-6377 doi:10.1128/JVI.00211-06.
52. Van der Loo B, Fenton MJ, Erusalimsky JD, (1998) Cytochemical Detection of a Senescence-Associated β-Galactosidase in Endothelial and Smooth Muscle Cells from Human and Rabbit Blood Vessels. Experimental Cell Research 241: 309-315 doi:10.1006/excr.1998.4035.
53. Hou M, Xu D, Björkholm M, Gruber A, (2001) Real-Time Quantitative Telomeric Repeat Amplification Protocol Assay for the Detection of Telomerase Activity. Clinical Chemistry 47: 519-524.
54. Zhu H, Zheng C, Xing J, Wang S, Li S, et al. (2011) Varicella-Zoster Virus Immediate-Early Protein ORF61 Abrogates the IRF3-Mediated Innate Immune Response through Degradation of Activated IRF3. Journal of Virology 85: 11079-11089 doi:10.1128/JVI.05098-11.
55. Hardy GAD, Sieg SF, Rodriguez B, Jiang W, Asaad R, et al. (2009) Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression. Blood 113: 5497-5505 doi:10.1182/blood-2008-11-190231.
56. Kuo R-L, Zhao C, Malur M, Krug RM, (2010) Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. Virology 408: 146-158 doi:10.1016/j.virol.2010.09.012.
57. Eidson KM, Hobbs WE, Manning BJ, Carlson P, DeLuca NA, (2002) Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection. J Virol 76: 2180-2191 doi:10.1128/jvi.76.5.2180-2191.2002.
58. ATCC: Catalog Search (n.d.). Available:http://www.atcc.org/ATCCAdvancedCatalogSearch/ProductDetails/tabid/452/Default.aspx?ATCCNum=CCL-137&Template=cellBiology. Accessed 26 November 2012.
59. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific Association of Human Telomerase Activity with Immortal Cells and Cancer. Science 266: 2011-2015.
60. Klingelhutz AJ, Foster SA, McDougall JK, (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79-82 doi:10.1038/380079a0.
61. Chen QM, Tu VC, Catania J, Burton M, Toussaint O, et al. (2000) Involvement of Rb family proteins, focal adhesion proteins and protein synthesis in senescent morphogenesis induced by hydrogen peroxide. Journal of cell science 113: 4087-4097.
62. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America 92: 9363-9367 doi:VL-92.
63. Brailovsky CA, Berman LD, Chany C, (1969) Decreased interferon sensitivity and production in cells transformed by SV40 and other oncogenic agents. Int J Cancer 4: 194-203.
64. Fensterl V, Sen GC, (2011) The ISG56/IFIT1 Gene Family. Journal of Interferon & Cytokine Research 31: 71-78 doi:10.1089/jir.2010.0101.
65. Rathi AV, Cantalupo PG, Sarkar SN, Pipas JM, (2010) Induction of interferon-stimulated genes by Simian virus 40 T antigens. Virology 406: 202-211 doi:10.1016/j.virol.2010.07.018.
66. Mossman KL, Saffran HA, Smiley JR, (2000) Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon. J Virol 74: 2052-2056 doi:10.1128/JVI.74.4.2052-2056.2000.
67. Ito Y, Montagnier L, (1977) Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons. Infection and immunity 18: 23-27.
68. Stewart WE, Scott WD, Sulkin SE, (1969) Relative Sensitivities of Viruses to Different Species of Interferon. J Virol 4: 147-153.
69. Taylor RT, Bresnahan WA, (2005) Human Cytomegalovirus Immediate-Early 2 Gene Expression Blocks Virus-Induced Beta Interferon Production. J Virol 79: 3873-3877 doi:10.1128/JVI.79.6.3873-3877.2005.
70. Langford MP, Weigent DA, Stanton GJ, Baron S, (1981) Virus plaque-reduction assay for interferon: Microplaque and regular macroplaque reduction assays. In: Academic Press, Vol. Volume Sidney Pestka, editor. Methods in Enzymology. 78: 339-346.
71. Collins SE, Noyce RS, Mossman KL, (2004) Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication. J Virol 78: 1706-1717 doi:10.1128/JVI.78.4.1706-1717.2004.
72. Mossman KL, Smiley JR, (2002) Herpes Simplex Virus ICP0 and ICP34.5 Counteract Distinct Interferon-Induced Barriers to Virus Replication. J Virol 76: 1995-1998 doi:10.1128/JVI.76.4.1995-1998.2002.
73. Norman KL, Farassati F, Lee PWK, (2001) Oncolytic viruses and cancer therapy. Cytokine & Growth Factor Reviews 12: 271-282 doi:10.1016/S1359-6101(00)00024-1.
74. Barber GN, (2005) VSV-tumor selective replication and protein translation. Oncogene 24: 7710-7719 doi:10.1038/sj.onc.1209042.
75. Cai WZ, Schaffer PA, (1991) A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1. J Virol 65: 4078-4090.
76. Douglas JL, Quinlan MP, (1995) Efficient nuclear localization and immortalizing ability, two functions dependent on the adenovirus type 5 (Ad5) E1A second exon, are necessary for cotransformation with Ad5 E1B but not with T24ras. J Virol 69: 8061-8065.
77. Bartek J, Bartkova J, Kyprianou N, Lalani EN, Staskova Z, et al. (1991) Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proceedings of the National Academy of Sciences 88: 3520.
78. Wazer DE, Liu XL, Chu Q, Gao Q, Band V, (1995) Immortalization of Distinct Human Mammary Epithelial Cell Types by Human Papilloma Virus 16 E6 or E7. PNAS 92: 3687-3691.
79. Shay JW, Wright WE, Werbin H, (1991) Defining the molecular mechanisms of human cell immortalization. Biochimica et Biophysica Acta (BBA)- Reviews on Cancer 1072: 1-7 doi:10.1016/0304-419X(91)90003-4.
80. Ahuja D, S{pipe}[aacute]{pipe}enz-Robles MT, Pipas JM, (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24: 7729-7745 doi:10.1038/sj.onc.1209046.
81. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, et al. (1999) The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. The EMBO Journal 18: 2449-2458 doi:10.1093/emboj/18.9.2449.
82. Patel D, Huang S-M, Baglia LA, McCance DJ, (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. The EMBO Journal 18: 5061-5072 doi:10.1093/emboj/18.18.5061.
83. Ali SH, DeCaprio JA, (2001) Cellular transformation by SV40 large T antigen: interaction with host proteins. Seminars in Cancer Biology 11: 15-23 doi:10.1006/scbi.2000.0342.
84. Valls E, De la Cruz X, Martínez-Balbás MA, (2003) The SV40 T antigen modulates CBP histone acetyltransferase activity. Nucleic Acids Res 31: 3114-3122.
85. Frisch SM, Mymryk JS, (2002) Adenovirus-5 E1A: paradox and paradigm. Nature Reviews Molecular Cell Biology 3: 441-452 doi:10.1038/nrm827.
86. Brockmann D, Esche H, (2003) The multifunctional role of E1A in the transcriptional regulation of CREB/CBP-dependent target genes. Curr Top Microbiol Immunol 272: 97-129.
87. Hyland PL, McDade SS, McCloskey R, Dickson GJ, Arthur K, et al. (2011) Evidence for Alteration of EZH2, BMI1 and KDM6A and Epigenetic Reprogramming in Human Papillomavirus Type-16 E6/E7 Expressing Keratinocytes. J Virol. Available:http://jvi.asm.org/content/early/2011/08/24/JVI.00160-11. Accessed 2012 June 18.
88. Li HP, Leu YW, Chang YS, (2005) Epigenetic changes in virus-associated human cancers. Cell Research 15: 262-271 doi:10.1038/sj.cr.7290295.
89. Cantalupo PG, Sáenz-Robles MT, Rathi AV, Beerman RW, Patterson WH, et al. (2009) Cell-type specific regulation of gene expression by simian virus 40 T antigens. Virology 386: 183-191 doi:10.1016/j.virol.2008.12.038.
90. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, et al. (1996) Two Contact Regions Between Stat1 and CBP/P300 in Interferon Γ Signaling. PNAS 93: 15092-15096.
91. Ronco LV, Karpova AY, Vidal M, Howley PM, (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12: 2061-2072 doi:10.1101/gad.12.13.2061.
92. Sundararajan R, White E, (2001) E1B 19K Blocks Bax Oligomerization and Tumor Necrosis Factor Alpha-Mediated Apoptosis. J Virol 75: 7506-7516 doi:10.1128/JVI.75.16.7506-7516.2001.
93. Han J, Sabbatini P, Perez D, Rao L, Modha D, et al. (1996) The E1B 19K Protein Blocks Apoptosis by Interacting with and Inhibiting the P53-Inducible and Death-Promoting Bax Protein. Genes Dev 10: 461-477 doi:10.1101/gad.10.4.461.
94. Debbas M, White E, (1993) Wild-Type P53 Mediates Apoptosis by E1A, Which Is Inhibited by E1B. Genes Dev 7: 546-554 doi:10.1101/gad.7.4.546.
95. Rajan P, Swaminathan S, Zhu J, Cole CN, Barber G, et al. (1995) A novel translational regulation function for the simian virus 40 large-T antigen gene. J Virol 69: 785-795.
96. Lindvall C, Hou M, Komurasaki T, Zheng C, Henriksson M, et al. (2003) Molecular Characterization of Human Telomerase Reverse Transcriptase-immortalized Human Fibroblasts by Gene Expression Profiling: Activation of the Epiregulin Gene. Cancer Res 63: 1743-1747.
97. Bresnahan WA, Hultman GE, Shenk T, (2000) Replication of Wild-Type and Mutant Human Cytomegalovirus in Life-Extended Human Diploid Fibroblasts. J Virol 74: 10816-10818 doi:10.1128/JVI.74.22.10816-10818.2000.
98. McSharry BP, Jones CJ, Skinner JW, Kipling D, Wilkinson GWG, (2001) Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus. J Gen Virol 82: 855-863.
99. Xin H, Pereira-Smith OM, Choubey D, (2004) Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 23: 6209-6217 doi:10.1038/sj.onc.1207836.
100. Nguyen ML, Kraft RM, Aubert M, Goodwin E, DiMaio D, et al. (2007) p53 and hTERT Determine Sensitivity to Viral Apoptosis. J Virol 81: 12985-12995 doi:10.1128/JVI.01485-07.
101. Lilley CE, Chaurushiya MS, Boutell C, Everett RD, Weitzman MD, (2011) The Intrinsic Antiviral Defense to Incoming HSV-1 Genomes Includes Specific DNA Repair Proteins and Is Counteracted by the Viral Protein ICP0. PLoS Pathog 7: e1002084 doi:10.1371/journal.ppat.1002084.
102. Halford W, Weisend C, Grace J, Soboleski M, Carr D, et al. (2006) ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virology Journal 3: 44 doi:10.1186/1743-422X-3-44.
103. Kalamvoki M, Roizman B, (2009) ICP0 enables and monitors the function of D cyclins in herpes simplex virus 1 infected cells. Proceedings of the National Academy of Sciences 106: 14576-14580 doi:10.1073/pnas.0906905106.